ATACAND Search (10 Results)

BioPortfolio.com - BioWeb ZESTRIL LISINOPRIL zenica. astrazenneca ...

Atacand, Amias, Hytacand, (candesartan cilexetil) - angiotensin II antagonist - AstraZeneca pharmaceutical products. Skip to content Home Media Investors ...

http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe%3FDB%3Dsearch%26%2520cgi%3DSAVEDB%2...
Hypertension: Competing Treatments and Market Entry Considerations

Atacand®), telmisartan (e.g. Micardis®), eprosartan (e.g. Teveten®), irbesartan (e.g. Avapro®), valsartan (e.g. Diovan®) or others (specified). * Statins. ...

http://www.bioportfolio.com/cgi-bin/acatalog/Hypertension-Competing-Treatments-and-Market-...
BioPortfolio.com - BioWeb COMTAN ENTACAPONE thereapeut ...

... Labeling Updated-7/99) Alamast Alinia Aloxi Alrex Amerge Angiomax Antagon Arava Argatroban Arixtra Aromasin Atacand Avandia Avelox (New Dosage Form and ...

http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe%3FDB%3Dsearch%26CMD%3Dexpand.auto%2...
Kidneys and Genito-Urinary System Diabetic Nephropathy Therapy ...

... ARIA(Atacand Renoprotection In NephropAthy Pt.) :: Last Updated: 14:51 EST Monday the 19th of July 2010 | 0 views total; The Genetics of Kidneys in ...

http://www.bioportfolio.com/store/product/1147/Kidneys-And-Genito-urinary-System-Diabetic-...
Diabetes Market Forecast to 2013 (TA221)

26 Aug 2010 ... Atacand * Epicept NP-1 * Qnexa PRODUCT PROFILE COMPONENTS * Drug's development and approval history * Competitive and strategic positioning ...

http://www.bioportfolio.com/store/product/1794/Diabetes-Market-Forecast-To-2013-ta221
(1)H, (15)N and (13)C resonance assignment of darcin, a mouse ...

ARIA(Atacand Renoprotection In NephropAthy Pt.) :: Last Updated: 14:51 EST Monday the 19th of July 2010 | 0 views total; Study Evaluating the Effect of ...

http://www.bioportfolio.com/resources/pmarticle/43678/1-H-15-N-and-13-C-resonance-assignme...
Acute-Heart-Failure-Drug-Pipeline-Analysis-and-Market-Forecasts-to ...

20 Aug 2010 ... 3.3.5 Atacand (Candesartan) 15 3.3.6 Bidil (Isosorbide Dinitrate and Hydralazine Hydrochloride) 16 3.4 Key Takeaway 17 ...

http://www.bioportfolio.com/store/product/1226/Acute-Heart-Failure-Drug-Pipeline-Analysis-...
World AMD and Diabetic Retinopathy Pharmaceutical Market 2009-2024

7 Aug 2009 ... 5.5.24 Atacand/TCV-116 (AstraZeneca) 5.5.25 Microplasmin (ThromboGenics) 5.5.26 RPE65 Gene Therapy (Targeted Genetics) ...

http://www.bioportfolio.com/store/product/259/World-AMD-and-Diabetic-Retinopathy-Pharmaceu...
World Ophthalmic Pharmaceutical Market 2010-2025

25 Jan 2010 ... 10.6.6 Atacand/TCV-116 (AstraZeneca/Takeda) 10.6.7 Medidur (pSivida/Alimera Sciences/Pfizer) 10.6.8 NT-501 (Neurotech) ...

http://www.bioportfolio.com/store/product/726/World-Ophthalmic-Pharmaceutical-Market-2010-...
Hypertension: Competing Treatments and Market Entry Considerations

21 Aug 2010... for the treatment of Hypertension: losartan (e.g. Cozaar®, Hyzaar®), olmesartan (e.g. Benicar®), candesartan (e.g. Atacand®), ...

http://www.bioportfolio.com/store/product/1646/Hypertension-Competing-Treatments-and-Marke...